Literature DB >> 20531225

MicroRNA-125a/b-5p inhibits endothelin-1 expression in vascular endothelial cells.

Dong Li1, Pengyuan Yang, Qinghui Xiong, Xuhui Song, Xiangqun Yang, Lin Liu, Wenjun Yuan, Yao-Cheng Rui.   

Abstract

BACKGROUND: Endothelin-1 (ET-1) is considered to be one of the most potent and long-lasting vasoconstrictive peptides, but the mechanisms on the regulation of ET-1 expression are not fully understood. METHOD AND
RESULTS: In this study, we found that microRNA (miR)-125a-5p and miR-125b-5p are highly expressed in vascular endothelial cells (VECs), which can be regulated by oxidized low-density lipoprotein (oxLDL). To explore the function of miR-125a/b-5p in VECs, we examined the roles of potential targets of miR-125a/b-5p that could influence endothelium function. We found that both miR-125a/b-5p can suppress oxLDL-induced ET-1 expression by directly targeting 3' untranslated region of prepro-endothelin-1 (preproET-1) mRNA determined by luciferase reporter assay, western blot, and enzyme immunometric assay. Consistently, inhibitors of miR-125a/b-5p can directly enhance preproET-1 expression. The decreased expressions of miR-125a-5p and miR-125b-5p are negatively associated with upregulation of preproET-1 expression in aorta of stroke-prone spontaneously hypertensive rats (SHR-SPs).
CONCLUSION: Our finding demonstrated that endothelial miR-125a/b-5p inhibits ET-1 expression in VECs, which revealed a novel miRNA-mediated mechanism in vasomotor homeostasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20531225     DOI: 10.1097/HJH.0b013e32833a4922

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  57 in total

Review 1.  Role of microRNAs in endothelial inflammation and senescence.

Authors:  Bing Qin; Huan Yang; Bo Xiao
Journal:  Mol Biol Rep       Date:  2011-09-28       Impact factor: 2.316

Review 2.  Noncoding RNAs in Cardiovascular Disease: Pathological Relevance and Emerging Role as Biomarkers and Therapeutics.

Authors:  Roopesh S Gangwar; Sanjay Rajagopalan; Rama Natarajan; Jeffrey A Deiuliis
Journal:  Am J Hypertens       Date:  2018-01-12       Impact factor: 2.689

Review 3.  The Epigenetic Machinery in Vascular Dysfunction and Hypertension.

Authors:  Emile Levy; Schohraya Spahis; Jean-Luc Bigras; Edgard Delvin; Jean-Michel Borys
Journal:  Curr Hypertens Rep       Date:  2017-06       Impact factor: 5.369

Review 4.  MicroRNAs: new players in heart failure.

Authors:  Vagner Oliveira-Carvalho; Miguel Morita Fernandes da Silva; Guilherme Veiga Guimarães; Fernando Bacal; Edimar Alcides Bocchi
Journal:  Mol Biol Rep       Date:  2012-12-15       Impact factor: 2.316

Review 5.  Hemodynamics mediated epigenetic regulators in the pathogenesis of vascular diseases.

Authors:  C L Karthika; S Ahalya; N Radhakrishnan; C C Kartha; S Sumi
Journal:  Mol Cell Biochem       Date:  2020-08-25       Impact factor: 3.396

6.  MicroRNA 648 Targets ET-1 mRNA and is cotranscriptionally regulated with MICAL3 by PAX5.

Authors:  Chen Li; Caryn S Gonsalves; Marthe-Sandrine Eiymo Mwa Mpollo; Punam Malik; Stanley M Tahara; Vijay K Kalra
Journal:  Mol Cell Biol       Date:  2014-11-17       Impact factor: 4.272

Review 7.  Non-coding RNA regulation of endothelial and macrophage functions during atherosclerosis.

Authors:  Binod Aryal; Yajaira Suárez
Journal:  Vascul Pharmacol       Date:  2018-03-15       Impact factor: 5.773

Review 8.  MicroRNAs in endothelial cell homeostasis and vascular disease.

Authors:  Carlos Fernández-Hernando; Yajaira Suárez
Journal:  Curr Opin Hematol       Date:  2018-05       Impact factor: 3.284

9.  Endogenous microRNAs in human microvascular endothelial cells regulate mRNAs encoded by hypertension-related genes.

Authors:  Alison J Kriegel; Maria Angeles Baker; Yong Liu; Pengyuan Liu; Allen W Cowley; Mingyu Liang
Journal:  Hypertension       Date:  2015-08-17       Impact factor: 10.190

Review 10.  MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases.

Authors:  Juan F Aranda; Julio Madrigal-Matute; Noemi Rotllan; Carlos Fernández-Hernando
Journal:  Free Radic Biol Med       Date:  2013-07-17       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.